您即将离开沛嘉医疗中文官网。
您刚才点击了进入另一网站的链接。如果继续,您可能会进入由第三方运行的网站。 我们不负责对非沛嘉医疗中文官网上的内容进行审核与管控,亦不会对您在非沛嘉医疗中文网上的任何商业交易或事物承担任何责任。您使用其他网站时,必须遵循该网站的使用条款及隐私声明。 其他网站上的部分产品和信息可能并未在您所在地区或国家获得批准。
取消
继续
Brief News on Innovation
Company News Brief News on Innovation
Brief News on Innovation
INNOVATIVE TRANSCATHETER EDGETO-EDGE REPAIR (TEER) SYSTEM GeminiOne®: RESULTS OF DMR TREATMENT PUBLISHED FOR THE FIRST TIME
2024.04.15
INNOVATIVE TRANSCATHETER EDGETO-EDGE RE···
On April 12, 2024, the results of GeminiOne® for DMR were published in JACC: Case Reports, a leading···
Trilogy™ THV SYSTEM FOR AR INDICATION: RESULTS FROM ALIGN-AR PIVOTAL TRIAL WERE PUBLISHED IN THE LANCET
2024.03.29
Trilogy™ THV SYSTEM FOR AR INDICATION: R···
On March 26, 2024, the exciting results of JenaValve TrilogyTM System’s pivotal clinical trial, ALIG···
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKED DRY-TISSUE TAVR SYSTEM COMPLETED ALL PATIENT ENROLLMENT OF ITS PIVOTAL CLINICAL TRIAL
2024.03.01
TaurusNXT® NON-GLUTARALDEHYDE CROSSLINKE···
In February 2024, TaurusNXT® Non-glutaraldehyde Crosslinked dry-tissue TAVR system, a thirdgenerati···
TaurusAtlas Pro, THE SECOND-GENERATION BALLOON DILATATION CATHETER, HAS BEEN APPROVED BY THE NMPA
2024.02.01
TaurusAtlas Pro, THE SECOND-GENERATION B···
The registration application of TaurusAtlas Pro, the second-generation balloon dilatation catheter i···
TaurusTrio AR TAVR SYSTEM COMPLETED ALL PATIENT ENROLLMENT OF ITS MULTI-CENTER PIVOTAL CLINICAL TRIAL
2024.01.29
TaurusTrio AR TAVR SYSTEM COMPLETED ALL ···
In January 2024, TaurusTrio AR TAVR System  successfully completed patient enrollment in its mu···
Academic Conferences at Home and Abroad are in Full Swing, Where Peijia Medical Has  Showcased a Variety of Products and Received Enthusiastic Responses
2023.12.29
Academic Conferences at Home and Abroad ···
❖ TaurusOne® Transcatheter Aortic Valve Replacement (TAVR) System■ Four-Year Clinical Follow-up Resu···
Shanghai Renji Hospital Completed the First Patient Enrollment of the Registration Clinical  Trial of Achieva’s CereStellar™ Intracranial Assist Stent
2023.12.22
Shanghai Renji Hospital Completed the Fi···
Achieva Medical initiated a prospective, multi-center, randomized-controlled clinical trial to evalu···
Prof. Yu Bo's Team at the Second Affiliated Hospital of Harbin Medical University  Successfully Completed the First Enrollment at the Chinese Clinical Trial Center for Peijia  HighLife® Trans-septal Mitral Valve Replacement (TSMVR) System
2023.11.01
Prof. Yu Bo's Team at the Second Affilia···
On October 31, 2023, the team led by Prof. Yu Bo at the Second Affiliated Hospital of Harbin Medical···
Professor Song Guangyuan and His Team at Beijing Anzhen Hospital have Successfully  Completed the First Day Enrollment in the Multi-Center Registration Clinical Trial of  TaurusTrio™
2023.07.31
Professor Song Guangyuan and His Team at···
On July 26, 2023, Professor Song Guangyuan, the Director of the Heart Valve Intervention Center at B···
NMPA APPROVAL FOR REGISTRATION APPLICATION OF DCwire™ MICRO GUIDEWIRE
2023.07.07
NMPA APPROVAL FOR REGISTRATION APPLICATI···
This announcement is made by Peijia Medical Limited (the “Company”, together with its subsidiaries,···
First Asian Commercial Implants with the Trilogy Heart Valve System performed by Dr. Michael Lee and His Team in Queen Elizabeth Hospital in Hong Kong
2023.05.18
First Asian Commercial Implants with the···
On May 12th, 2023, Dr. Michael Lee and his team from the Cardiology Department of Queen Elizabeth Ho···
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER REGISTRATION CLINICAL TRIAL OF GeminiOne® TRANSCATHETER EDGE-TO-EDGE REPAIR SYSTEM IN CHINA
2022.12.04
FIRST PATIENT ENROLLMENT IN THE MULTI-CE···
FIRST PATIENT ENROLLMENT IN THE MULTI-CENTER REGISTRATION CLINICAL TRIAL OF GeminiOne® TRANSCATHET···
Top